Press Releases Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Delayed Australian S.E. Other stock markets 11:01:53 08/05/2024 am IST			5-day change	1st Jan Change
7.095 ^AUD	-2.41%		+4.41%	+15.45%

26/02	Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	MT
25/02	Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MAYNE PHARMA REPORTS 1H FY24 RESULTS WITH A 43% INCREASE IN REVENUE TO A$188 MILLION AND $8 MILLION UNDERLYING EBITDA	27/02	AQ
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference	30/12	AQ
MAYNE PHARMA PROVIDES UPDATE ON FIRST QUARTER 2024 TRADING AND OUTLOOK	19/23/19	AQ
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition	10/23/10	AQ
Mayne Pharma and Mithra announce US launch of HALOETTE, a generic version of NUVARING	16/23/16	AQ
MAYNE PHARMA COMPLETES SALE OF METRICS CONTRACT SERVICES	05/22/05	AQ
MAYNE PHARMA - APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR	29/22/29	AQ
MAYNE PHARMA GROUP - NON-EXECUTIVE DIRECTOR APPOINTMENT AND RETIREMENT	31/22/31	AQ
Mayne Pharma : CEO announces plan to retire	19/22/19	PU
Mayne Pharma : announces sale of Metrics Contract Services	10/22/10	PU
Mayne Pharma : and Mithra announce FDA approval of Haloette, a generic version of Nuvaring	08/22/08	PU
MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS AND EXPAND ACCESS TO BIRTH CONTROL	01/22/01	AQ
Mayne Pharma Group Limited and Mithra Pharmaceuticals - NEXTSTELLIS ORAL CONTRACEPTIVE NOW AVAILABLE IN AUSTRALIA	27/22/27	AQ
Mayne Pharma : New Chief Financial Officer appointment	22/22/22	PU
Mayne Pharma : Wilsons investor conference presentation	26/22/26	PU
MAYNE PHARMA ANNOUNCED AS RECIPIENT OF $4.8M FEDERAL GOVERNMENT GRANT	09/22/09	AQ
Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT	22/22/22	AQ
Mayne Pharma : 22/03/2022 Non Executive Director Appointment	22/22/22	PU
MAYNE PHARMA REPORTS 1HFY22 RESULTS	28/22/28	AQ
Mayne Pharma : 2022 Half Year Investor Presentation	25/22/25	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Press Releases

Filters